Previous studies have demonstrated that metformin can increase the expression of SIRT3 and GPX4, significantly elevate the levels of p-mTOR and p-AMPK, and improve polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis (68). Here, SIRT3 is linked to polycystic ovary syndrome.